Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area apoptosis tnf'

Search results for: 'research area apoptosis tnf'

Items 1-10 of 32

Page
per page
  1. Lenalidomide (CC-5013)
    A4211 Lenalidomide (CC-5013)
    Target: angiogenesis
    Summary: Antineoplastic agent,inhibits angiogenesis
      insoluble in EtOH; insoluble in H2O; ≥100.8 mg/mL
  2. Pomalidomide (CC-4047)
    A4212 Pomalidomide (CC-4047)
    Summary: Immunomodulator,antumor/anti-angiogenic
      insoluble in EtOH; insoluble in H2O; ≥7.5 mg/mL
  3. Celastrol
    A2604 Celastrol
    Target: Proteasome
    Summary: Antioxidant, anti-inflammatory and immunosuppressive agent
      ≥22.55 mg/mL
  4. Bay 11-7821 (BAY 11-7082)
    A4210 Bay 11-7821 (BAY 11-7082)
     1 Citation
    Summary: IKK/NF-κB/TNFα inhibitor
      insoluble in H2O; ≥64 mg/mL
  5. YM155
    A4221 YM155
     2 Citation
    Target: Survivin
    Summary: Survivin suppressant,apoptosis inhibitor
      ≥22.15 mg/mL
  6. GDC-0152
    A4224 GDC-0152
     2 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: IAP antagonist,potent amd samll-molecule
      ≥24.95 mg/mL
  7. LCL161
    A3541 LCL161
     1 Citation
    Target: Inhibitor of apoptosis proteins (IAP)
    Summary: Antagonist of IAPs inhibitor
      ≥25.05 mg/mL
  8. 2,3-DCPE hydrochloride
    A4447 2,3-DCPE hydrochloride
    Target: Apoptosis Inducers
    Summary: Bcl-XL protein expression downregulator
      <30.06 mg/mL
  9. PAC-1
    A8177 PAC-1
     1 Citation
    Target: Caspases
    Summary: Procaspase-3 activator
      insoluble in H2O; ≥13.4 mg/mL
  10. RG7112
    A3762 RG7112
     5 Citation
    Target: MDM2
    Summary: MDM2 inhibitor, first clinical
      ≥36.4 mg/mL

Items 1-10 of 32

Page
per page